{"id":2434,"date":"2025-01-14T18:31:17","date_gmt":"2025-01-14T15:31:17","guid":{"rendered":"https:\/\/dmdwarrior.com\/?p=2434"},"modified":"2025-01-14T18:31:19","modified_gmt":"2025-01-14T15:31:19","slug":"immunoforge-receives-fda-ind-approval-for-phase-2-clinical-trial-of-pemziviptadil-for-dmd-cardiomyopathy","status":"publish","type":"post","link":"https:\/\/dmdwarrior.com\/fr\/immunoforge-receives-fda-ind-approval-for-phase-2-clinical-trial-of-pemziviptadil-for-dmd-cardiomyopathy\/","title":{"rendered":"ImmunoForge re\u00e7oit l&#039;approbation FDA IND pour l&#039;essai clinique de phase 2 du \u00ab Pemziviptadil \u00bb pour la cardiomyopathie DMD"},"content":{"rendered":"<p class=\"wp-block-paragraph\">M\u00e9dicament utilis\u00e9 pour la cardiomyopathie DMD, le pemziviptadil est utilis\u00e9 une fois par semaine et est bas\u00e9 sur la plateforme ELP (Elastin Like Polypeptide Platform) d&#039;ImmunForge, une plateforme pharmacologique \u00e0 action prolong\u00e9e. Afin d&#039;am\u00e9liorer la fonction cardiaque, le pemziviptadil, un peptide intestinal vasoactif (VIP), agit pr\u00e9f\u00e9rentiellement sur le r\u00e9cepteur 2 du peptide intestinal vasoactif (VPAC2) pour favoriser la contraction et la relaxation cardiaques.<\/p>","protected":false},"excerpt":{"rendered":"<p>M\u00e9dicament utilis\u00e9 pour la cardiomyopathie DMD, le pemziviptadil est utilis\u00e9 une fois par semaine et est bas\u00e9 sur la plateforme ELP (Elastin Like Polypeptide Platform) d&#039;ImmunForge, une plateforme pharmacologique \u00e0 action prolong\u00e9e. Afin d&#039;am\u00e9liorer la fonction cardiaque, le pemziviptadil, un peptide intestinal vasoactif (VIP), agit pr\u00e9f\u00e9rentiellement sur le r\u00e9cepteur 2 du peptide intestinal vasoactif (VPAC2) pour favoriser la contraction et la relaxation cardiaques.<\/p>","protected":false},"author":1,"featured_media":2436,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[27],"tags":[66,156,157,159,158],"class_list":["post-2434","post","type-post","status-publish","format-standard","has-post-thumbnail","category-research","tag-duchenne-muscular-dystrophy","tag-immunoforge","tag-pemziviptadil","tag-pf1804","tag-south-korea"],"_links":{"self":[{"href":"https:\/\/dmdwarrior.com\/fr\/wp-json\/wp\/v2\/posts\/2434","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dmdwarrior.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dmdwarrior.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/fr\/wp-json\/wp\/v2\/comments?post=2434"}],"version-history":[{"count":0,"href":"https:\/\/dmdwarrior.com\/fr\/wp-json\/wp\/v2\/posts\/2434\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/fr\/wp-json\/wp\/v2\/media\/2436"}],"wp:attachment":[{"href":"https:\/\/dmdwarrior.com\/fr\/wp-json\/wp\/v2\/media?parent=2434"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dmdwarrior.com\/fr\/wp-json\/wp\/v2\/categories?post=2434"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dmdwarrior.com\/fr\/wp-json\/wp\/v2\/tags?post=2434"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}